Ci Private Wealth, LLC Fate Therapeutics Inc Transaction History
Ci Private Wealth, LLC
- $59.6 Billion
- Q1 2025
A detailed history of Ci Private Wealth, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Ci Private Wealth, LLC holds 29,649 shares of FATE stock, worth $34,689. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,649
Previous 29,649
-0.0%
Holding current value
$34,689
Previous $48,000
52.08%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding FATE
# of Institutions
158Shares Held
97.8MCall Options Held
45.8KPut Options Held
15.9K-
Redmile Group, LLC San Francisco, CA12.9MShares$15.1 Million1.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$12.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$11.8 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.38MShares$5.13 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.56MShares$4.16 Million0.15% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $113M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...